Mednax (MD) Tops Q2 EPS by 3c; Guides Q3 EPS; Comps Growth of 1.5% in Q212
Tweet Send to a FriendGet Alerts MD Hot Sheet
Trade MD Now!
Mednax (NYSE: MD) reported Q2 EPS of $1.22, $0.03 better than the analyst estimate of $1.19. Revenue for the quarter came in at $449.5 million versus the consensus estimate of $437.33 million.
Same-unit growth attributable to patient volume grew by 1.5 percent.
Mednax sees Q3 2012 EPS of $1.25-$1.30, versus the consensus of $1.26.
For earnings history and earnings-related data on Mednax (MD) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Same-unit growth attributable to patient volume grew by 1.5 percent.
Mednax sees Q3 2012 EPS of $1.25-$1.30, versus the consensus of $1.26.
For earnings history and earnings-related data on Mednax (MD) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Best Buy (BBY) Posts Q1 adj.-EPS of 32c; Comps Down 1.1%
- Campbell Soup Co. (CPB) Tops Q3 EPS by 6c; Boosts FY13 Outlook
- Sina Corp (SINA) Tops Q1 EPS by 5c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
